Skip to main content
. 2024 Sep 20;18(3):203–211. doi: 10.1097/CU9.0000000000000248

Table 3.

Change in frequency of nocturia at weeks 6, 12, 18, and 24.

Study time point RCT Fem™ UI Mean ± SD (n) Within-group p* PollenBerry® Mean ± SD (n) Within-group p* Placebo Mean ± SD (n) Within-group p* p RCT Fem™ UI vs. placebo* PollenBerry® vs. placebo*
Change from baseline at week 6 −0.06 ± 1.11 (32) 0.75 0.15 ± 0.87 (33) 0.32 0.18 ± 1.45 (38) 0.44 0.42
0.91
Change from baseline at week 12 −0.32 ± 0.98 (29) 0.08 0.16 ± 0.93 (31) 0.34 −0.24 ± 0.88 (38) 0.11 0.71
0.08
Change from baseline at week 18 −0.17 ± 2.22 (29) 0.68 −0.25 ± 0.75 (28) 0.09 −0.21 ± 0.81 (38) 0.12 0.93
0.84
Change from baseline at week 24 −0.52 ± 1.26 (25) 0.05 −0.12 ± 0.74 (24) 0.42 −0.38 ± 0.89 (37) 0.01 0.63
0.23

*The p values for between-group and within-group differences were generated using linear mixed-effects models.

Indicates a significant within-group difference from baseline.

SD = standard deviation; UI = urinary incontinence.